Brand variation in oxidant production in mainstream cigarette smoke: Carbonyls and free radicals

Food and Chemical Toxicology

Volumn 106, Issue , 2017, Pages 147-154

  Reilly, Samantha M ^a   Goel, Reema ^a   Trushin, Neil ^a   Elias, Ryan J ^b   Foulds, Jonathan ^a   Muscat, Joshua ^a   Liao, Jason ^a   Richie, John P ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Acetaldehyde; Crotonaldehyde; Formaldehyde; Methyl ethyl ketone; Oxidants; Propionaldehyde; Tobacco smoke

Indexed keywords

CARBONYL DERIVATIVE; CIGARETTE SMOKE; FORMALDEHYDE; FREE RADICAL; OXIDIZING AGENT; NITROSAMINE;

AIR CONDITIONING; ARTICLE; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; GAS; PARTICULATE MATTER; UNITED STATES; ANALYSIS; CHEMISTRY; CLASSIFICATION; SMOKE; TOBACCO;

FORMALDEHYDE; FREE RADICALS; NITROSAMINES; OXIDANTS; SMOKE; TOBACCO; TOBACCO PRODUCTS;

EID: 85019709302     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2017.05.035     Document Type: Article

References (45)

1. Baker, R.R., Pereira da Silva, J.R., Smith, G., The effect of tobacco ingredients on smoke chemistry. Part I: flavourings and additives. Food Chem. Toxicol. 42:Suppl. l (2004), S3–S37.
2. Baker, R.R., Pereira da Silva, J.R., Smith, G., The effect of tobacco ingredients on smoke chemistry. Part II: casing ingredients. Food Chem. Toxicol. 42:Suppl. l (2004), S39–S52.
3. Bodnar, J.A., Morgan, W.T., Murphy, P.A., Ogden, M.W., Mainstream smoke chemistry analysis of samples from the 2009 US cigarette market. Regul. Toxicol. Pharmacol. RTP 64 (2012), 35–42.
4. Burney, P., Jithoo, A., Kato, B., Janson, C., Mannino, D., Niżankowska-Mogilnicka, E., Studnicka, M., Tan, W., Bateman, E., Koçabas, A., Vollmer, W.M., Gislason, T., Marks, G., Koul, P.A., Harrabi, I., Gnatiuc, L., Buist, S., Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty—a BOLD analysis. Thorax 69 (2014), 465–473.
5. Burns, D.M., Dybing, E., Gray, N., Hecht, S., Anderson, C., Sanner, T., O'Connor, R., Djordjevic, M., Dresler, C., Hainaut, P., Jarvis, M., Opperhuizen, A., Straif, K., Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob. Control 17 (2007), 132–141.
6. Celebucki, C.C., Wayne, G.F., Connolly, G.N., Pankow, J.F., Chang, E.I., Characterization of measured menthol in 48 U.S. cigarette sub-brands. Nicotine Tob. Res. 7 (2005), 523–531.
7. Chen, M.S., Xu, Z.Q., Chen, G., Wang, H., Yin, C.Y., Zhou, Z.L., Sun, W.F., Li, Y., Zhong, F., The influence of exogenous fiber on the generation of carbonyl compounds in reconstituted tobacco sheet. J. Anal. Appl. Pyrol 105 (2014), 227–233.
8. Church, D.F., Pryor, W.A., Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. health Perspect. 64 (1985), 111–126.
9. CORESTA, Recommended method N° 74: determination of selected carbonyls in mainstream cigarette smoke by HPLC. CORESTA, 2014, CORESTA, Paris, France.
10. Counts, M.E., Hsu, F.S., Laffoon, S.W., Dwyer, R.W., Cox, R.H., Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. Regul. Toxicol. Pharmacol. RTP 39 (2004), 111–134.
11. Counts, M.E., Morton, M.J., Laffoon, S.W., Cox, R.H., Lipowicz, P.J., Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul. Toxicol. Pharmacol. RTP 41 (2005), 185–227.
12. Danaei, G., Ding, E.L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C.J., Ezzati, M., The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med., 6, 2009, 365.
13. Ding, Y.S., Xizheng, Y., Wong, J., Chan, M., Watson, C.H., In situ derivatization and quantification of seven carbonyls in cigarette mainstream smoke. Chem. Res. Toxicol. 29 (2015), 125–131.
14. Dittrich, D.J., Fieblekorn, R.T., Bevan, M.J., Rushforth, D., Murphy, J.J., Ashley, M., McAdam, K.G., Liu, C., Proctor, C.J., Approaches for the Design of Reduced Toxicant Emission Cigarettes. vol. 3, 2014, SpringerPlus, 1–23.
15. Doll, R., Hill, A.B., Smoking and carcinoma of the lung. Br. Med. J., 2, 1950, 739.
16. Goel, R., Bitzer, Z., Reilly, S.M., Trushin, N., Foulds, J., Muscat, J., Liao, J., Elias, R.J., Richie, J.P. Jr., Variation in free radical yields from U.S. Marketed cigarettes. Chem. Res. Toxicol. 30 (2017), 1038–1045.
17. Halliwell, B.B., Gutteridge, J.M.C., Free Radicals in Biology and Medicine. fifth ed., 2015, Oxford University Press, United Kingdom.
18. Hammond, D., O'Conner, R.J., Constituents in tobacco and smoke emissions from Canadian cigarettes. Tob. Control 17 (2008), i24–i31.
19. Heck, J.D., A review and assessment of menthol employed as a cigarette flavoring ingredient. Food Chem. Toxicol. 48:Suppl. 2 (2010), S1–S38.
20. Hoffman, A.C., The health effects of menthol cigarettes as compared to non-menthol cigarettes. Tob. Induc. Dis., 9(Suppl. 1), 2011, S7.
21. Hoffman, A.C., Simmons, D., Menthol cigarette smoking and nicotine dependence. Tob. Induc. Dis., 9(Suppl. 1), 2011, S5.
22. Hoffmann, D., Djordjevic, M.V., Brunnemann, K.D., Changes in cigarette design and composition over time and how they influence the yields of smoke constituents. J. Smok. Relat. Dis. 6 (1995), 9–23.
23. Hoffmann, D., Hoffmann, I., El-Bayoumy, K., The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol. 14 (2001), 767–790.
24. Kozlowski, L.T., Mehta, N.Y., Sweeney, C.T., Schwartz, S.S., Vogler, G.P., Jarvis, M.J., West, R.J., Filter ventilation and nicotine content of tobacco in cigarettes from Canada, the United Kingdom, and the United States. Tob. Control 7 (1998), 369–375.
25. Krupski, W.C., The peripheral vascular consequences of smoking. Ann. Vasc. Surg. 5 (1991), 291–304.
26. Kundu, T.K., Hille, R., Velayutham, M., Zweier, J.L., Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues. Archives Biochem. biophysics 460 (2007), 113–121.
27. Marcilla, A., Martinez, I., Berenguer, D., Gomez-Siurana, A., Beltran, M.I., Comparative study of the main characteristics and composition of the mainstream smoke of ten cigarette brands sold in Spain. Food Chem. Toxicol. 50 (2012), 1317–1333.
28. O'Connor, R.J., Hammond, D., McNeill, A., King, B., Kozlowski, L.T., Giovino, G.A., Cummings, K.M., How do different cigarette design features influence the standard tar yields of popular cigarette brands sold in different countries?. Tob. Control 17 (2008), I1–I5.
29. Pang, X., Lewis, A.C., Carbonyl compounds in gas and particle phases of mainstream cigarette smoke. Sci. Total Environ. 409 (2011), 5000–5009.
30. Pazo, D.Y., Moliere, F., Sampson, M.M., Reese, C.M., Agnew-Heard, K.A., Walters, M.J., Holman, M.R., Blount, B.C., Watson, C., Chambers, D.M., Mainstream smoke levels of volatile organic compounds in 50 US domestic cigarette brands smoked with the ISO and canadian intense protocols. Nicotine Tob. Res. 18:9 (2016), 1886–1894.
31. Pryor, W.A., Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ. health Perspect. 105:Suppl. 4 (1997), 875–882.
32. R Core Team, R: a Language and Environment for Statistical computing., R Foundation for Statistical Computing. 2016 Vienna, Austria.
33. Risner, C.H., Martin, P., Quantitation of formaldehyde, acetaldehyde, and acetone in sidestream cigarette smoke by high-performance liquid chromatography. J. Chromatogr. Sci. 32 (1994), 76–82.
34. Roemer, E., Schorp, M.K., Piadé, J.J., Seeman, J.I., Leyden, D.E., Haussmann, H.J., Scientific assessment of the use of sugars as cigarette tobacco ingredients: a review of published and other publicly available studies. Crit. Rev. Toxicol. 42 (2012), 244–278.
35. Roemer, E., Stabbert, R., Rustemeier, K., Veltel, D.J., Meisgen, T.J., Reininghaus, W., Carchman, R.A., Gaworski, C.L., Podraza, K.F., Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195 (2003), 31–52.
36. Salgado, M.V., Glantz, S.A., Direct disease-inducing effects of menthol through the eyes of tobacco companies. Tob. Control 20:Suppl. 2 (2011), ii44–48.
37. Seeman, J.I., Laffoon, S.W., Kassman, A.J., Evaluation of relationships between mainstream smoke acetaldehyde and “tar” and carbon monoxide yields in tobacco smoke and reducing sugars in tobacco blends of U.S. Commercial cigarettes. Inhal. Toxicol. 15 (2003), 373–395.
38. Sharma, A., Fix, B.V., Delnevo, C., Cummings, K.M., O'Conner, R.J., Trends in market share of leading cigarette brands in the USA: national survey on drug use and health 2002–2013. BMJ Open, 6, 2015 e008813.
39. U.S. Department of Health and Human Services, The Health Consequences of Smoking—50 Years of Progress: a Report of the Surgeon General., 2014, Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta.
40. U.S. Food and Drug Administration, F.a.D. Administration, (eds.) Harmful and potentially harmful constituents in tobacco products and tobacco smoke: established list, 2012, Food and Drug Administration.
41. Werley, M.S., Coggins, C.R., Lee, P.N., Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions. Regul. Toxicol. Pharmacol. 47 (2007), 189–203.
42. Wooten, J.B., Chouchane, S., McGrath, T.E., Chapter 2: tobacco smoke constituents affecting oxidative stress. Halliwell, B.B., Poulsen, H.E., (eds.) Cigarette Smoke and Oxidative Stress. Springer-Verlag Berlin Heidelberg, Germany, 2006.
43. Wynder, E.L., Graham, E.A., Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma: a study of six hundred and eighty-four proved cases. JAMA 143 (1950), 329–336.
44. Xu, X., Bishop, E.E., Kennedy, S.M., Simpson, S.A., Pechacek, T.F., Annual healthcare spending attributable to cigarette smoking: an update. Am. J. Prev. Med. 48 (2015), 326–333.
45. Zaher, C., Halbert, R., Dubois, R., George, D., Nonikov, D., Smoking-related diseases: the importance of COPD. Int. J. Tuberc. Lung Dis. 8 (2004), 1423–1428.